No four consecutive quarters could be summed for EPS (Diluted); these figures use the latest fiscal year, not a trailing twelve months.
Some figures named '(TTM)' on this payload are the latest FISCAL YEAR, not a trailing twelve months — eps_ttm (fiscal year ended 2025-12-31). No four consecutive quarters could be summed for them — for an IFRS 20-F filer that is every income-statement line (no quarterly income statement is tagged to EDGAR at all); for a US filer it is usually one line the quarterly tagging skips. Each field's own basis is on field_basis.
full derived coverage requires a plan
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.
— Months · distinct values (the real sample size).
Metric
Today
Own median
Own range
%ile
z
Sector med.
mo · distinct
15.90×
17.14×
42nd
−0.13σ
24.86×
66 · 63
15.9%
22.9%
no band (47 mo · 5 distinct)
—
—
−36.9%
47 · 5
ROIC (FY)
—
no reconstructed observations for this name and metric.
7.8%
15.4%
5th
−1.04σ
−21.3%
66 · 6
−22.5%
36.4%
18th
−0.40σ
5.1%
112 · 111
−10.9%
12.3%
no band (30 mo · 4 distinct)
—
—
8.4%
30 · 4
41.4%
—
no band (30 mo · 3 distinct)
—
—
9.0%
30 · 3
Market Cap
$94.10M
not reconstructed — market cap was removed from the historical pass (never a ranking factor, and a reconstructed share count carries look-ahead risk). The single stored value is the forward-captured snapshot, not a series.
Own median 17.14× × $0.63 = $10.80vs the $10.02 close · earnings held constant
Own multiple
P/E
Implied price
vs close
10th percentile
5.50×
$3.47
−65.4%
25th percentile
8.25×
$5.20
−48.1%
median
17.14×
$10.80
+7.8%
75th percentile
21.82×
$13.75
+37.2%
90th percentile
28.88×
$18.19
+81.5%
today
15.90×
$10.02
—
Reference computation · 66 monthly P/E observations in Full · EPS basis FY2025 EPS (Diluted) $0.63 · close $10.02 (2026-08-21)ⓘ
Not a forecast: each row re-prices today's filed earnings at a multiple this company itself once traded at. It abstains rather than guess on a loss year or a broken per-share basis.
Every month uses only what was filed by then, split-adjusted. Delisted names are absent and a trough year can throw one huge reading, so read the median, not the edges.
Percentile through time (point-in-time cohort)
Loading the monthly cohort placement…
▸Comp setname your own peers — pick a pool or add tickers
Covered pool$978.69B +7.6%/yr 2020→2025Concentration484 of 10,000fragmented · top 3 hold 22.9% · −25 pts since 2020FTLF0.0% · rank 161 of 349 · +0.0pp over 5y· CV 0.39 · σ 0.0pp
Who holds the poolCY2025 · bars scaled to the largest member
Growth, restated as sharewhere each pace has to END UP, by 2030
Its own realised pace0.0% → 0.0%
The pace the price requires— The growth today's price requires (our reverse-DCF) is a Pro metric — the realized-pace runway above is free.
FTLF share over time6 published years
Calendar year
2020
2021
2022
2023
2024
2025
Share of covered pool
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
coverage: 322 of the 385 members that…
Share of covered industry revenue · n=349 in Pharmaceuticals & Biotechnology · CY2025 pool · built 2026-08-22 not market shareⓘ
Covered filers only, not market share — private and uncovered companies are missing, so every share here reads high. Years are FX-converted and published only once most of the pool has filed.
